Here are the basics about each of the medicines below. Only the most common reactions are listed. Ask your doctor if you need to take any special steps. Use each of these drugs as advised by your doctor or the booklet they came with. If you have any questions, call your doctor.
Medicine may be used to treat hepatitis B or C. The goal is to limit or stop further liver damage. Hepatitis B treatment may work for a limited time and not lead to a cure. Sometimes, people with hepatitis C will be cured. Some of these may be used alone or with other medicine.
Alpha interferon is treats types B and C and is given as a shot. Alcohol must be stopped when using this drug.
Some problems are:
This drug is used to treat chronic hepatitis B.
Some problems are:
This drug is used to treat chronic hepatitis B.
Some problems are:
This drug is used to treat chronic hepatitis B.
Some problems are:
This drug is used to treat chronic hepatitis B.
Some problems are:
This drug is used to treat chronic hepatitis C.
Some problems are:
Common names:
These drugs are used to treat hepatitis C. They slow the growth of the disease.
Some problems are:
Common names:
These drugs are used to treat hepatitis C. They slow the growth of the disease.
Some problems are:
If you are taking medicine:
Acute hepatitis B virus (HBV) infection. EBSCO DynaMed Plus website. Available at:http://www.dynamed.com/topics/dmp~AN~T913216/Acute-hepatitis-B-virus-HBV-infection. Updated May 14, 2018. Accessed April 18, 2019.
Acute hepatitis C infection. EBSCO DynaMed Plus website. Available at:http://www.dynamed.com/topics/dmp~AN~T413896/Acute-hepatitis-C-infection. Updated November 15, 2018. Accessed April 18, 2019.
Chronic hepatitis B virus (HBV) infection. EBSCO DynaMed Plus website. Available at:http://www.dynamed.com/topics/dmp~AN~T115624/Chronic-hepatitis-B-virus-HBV-infection. Updated May 14, 2018. Accessed April 18, 2019.
Chronic hepatitis C infection. EBSCO DynaMed Plus website. Available at:http://www.dynamed.com/topics/dmp~AN~T115157/Chronic-hepatitis-C-infection. Updated January 31, 2019. Accessed April 18, 2019.
Hepatitis C—treatment of genotype 1. EBSCO DynaMed Plus website. Available at:http://www.dynamed.com/topics/dmp~AN~T908659/Hepatitis-C-treatment-of-genotype-1. Updated December 2, 2018. Accessed April 18, 2019.
Hepatitis C—treatment of genotypes 2-6. EBSCO DynaMed Plus website. Available at:http://www.dynamed.com/topics/dmp~AN~T906076/Hepatitis-C-treatment-of-genotypes-2-6. Updated December 2, 2018. Accessed April 18, 2019.
Hepatitis D virus (HDV) infection. EBSCO DynaMed Plus website. Available at:http://www.dynamed.com/topics/dmp~AN~T233684/Hepatitis-D-virus-HDV-infection. Updated May 14, 2018. Accessed April 18, 2019.
Hepatitis E virus (HEV) infection. EBSCO DynaMed Plus website. Available at:http://www.dynamed.com/topics/dmp~AN~T116562/Hepatitis-E-virus-HEV-infection. Updated February 28, 2018. Accessed April 18, 2019.
Overview of acute viral hepatitis. Merck Manual Professional Version website. Available at: https://www.merckmanuals.com/professional/hepatic-and-biliary-disorders/hepatitis/overview-of-acute-viral-hepatitis. Updated January 2019. Accessed April 18, 2019.
Overview of chronic hepatitis. Merck Manual Professional Version website. Available at: https://www.merckmanuals.com/professional/hepatic-and-biliary-disorders/hepatitis/overview-of-chronic-hepatitis. Updated January 2019. Accessed April 18, 2019.
Last reviewed February 2019 by David L. Horn, MD, FACP Last Updated: 4/18/2019
EBSCO Information Services is fully accredited by URAC. URAC is an independent, nonprofit health care accrediting organization dedicated to promoting health care quality through accreditation, certification and commendation.
This content is reviewed regularly and is updated when new and relevant evidence is made available. This information is neither intended nor implied to be a substitute for professional medical advice. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with questions regarding a medical condition.
To send comments or feedback to our Editorial Team regarding the content please email us at healthlibrarysupport@ebsco.com. Our Health Library Support team will respond to your email request within 2 business days.